Adaptive Biotechnologies Showcases clonoSEQ® Data at ASH, Highlighting Advances in Blood Cancer Care and MRD Assessment

Pfizer Showcases Advancements in Hematology and Breast Cancer at ASH and SABCS 2023

GeNeuro Presents Precision Medicine Approach for ALS at Global Symposium

Prevention and Screening Drive Majority of Cancer Death Reductions Over 45 Years

Alithea Genomics Launches MERCURIUS™ Full-Length DRUG-seq Technology for Large-Scale RNA Sequencing

AstraZeneca’s Imfinzi (Durvalumab) Approved for Limited-Stage Small Cell Lung Cancer in the U.S.

BioLizard Launches Bio|Verse Navigator: Transforming Biomedical Data into Insights

Foresight Diagnostics Launches SHORTEN-ctDNA Trial to Personalize DLBCL Treatment and Reduce Toxicity

Thermo Fisher Scientific Unveils CTS™ Detachable Dynabeads™ CD4 and CD8 for Advanced Cell Therapy

Oncocyte Unveils Breakthrough Liquid Biopsy for Brain Tumor Diagnostics with DetermaCNI™

FDA Approves BIZENGRI® for NRG1+ Pancreatic Cancer and NSCLC

REVEAL GENOMICS and IEO Launch Impact Study on HER2DX® Test to Advance Personalized Treatment in HER2+ Breast Cancer

FDA Grants Breakthrough Therapy Designation to Merck’s Sacituzumab Tirumotecan for EGFR-Mutated NSCLC

Spur Therapeutics Unveils SPR301: A Novel Gene Therapy for GBA1-Linked Parkinson’s Disease

M | O | C Cancer Care & Research Centre Achieves CAR-T Therapy Milestone